Austrian Academy of Sciences Reprimands Mathematician Karl Sigmund Over Epstein Meetings but Retains Membership

Sigmund, who was the doctoral advisor to biologist Martin Nowak—another figure linked to Epstein—acknowledged the meetings when the ethics committee was established. He told ORF Wissen that he met Epstein because he "wanted to form a personal impression" of the financier.

Epstein’s Ties to Academia

Jeffrey Epstein, whose criminal activities included sexually abusing hundreds of young women and minors, cultivated relationships with prominent scientists, including Nowak. Nowak, who had frequent personal contact with Epstein and received generous donations for his research, has repeatedly distanced himself from Epstein’s crimes.

In previous statements, Nowak stressed that he "deeply abhors the criminal acts of Jeffrey Epstein" and had no personal knowledge of them. The ORF reported that Sigmund met Epstein in New York in September 2018 and again in Vienna in March 2019.

The case highlights the ethical dilemmas faced by academic institutions when their members associate with controversial figures. The ÖAW’s decision to retain Sigmund while formally condemning his actions reflects a balancing act between accountability and preserving academic freedom.

Broader Implications

The scrutiny of Sigmund’s ties to Epstein follows a wider reckoning with Epstein’s influence in scientific circles. Epstein’s network extended across academia, with some researchers accepting funding from him despite his notoriety. The ÖAW’s handling of the case may set a precedent for how other institutions address similar controversies.

While Sigmund’s membership remains intact, the reprimand underscores the academy’s stance on maintaining ethical standards. The decision also raises questions about how academic institutions should evaluate collaborations with ethically compromised benefactors in the future.

The ÖAW has not commented on whether further actions will be taken regarding other members with Epstein connections. However, the case signals a heightened awareness of the need for transparency and accountability in scientific partnerships.